161 related articles for article (PubMed ID: 12398837)
1. Inclusion body myositis: morphological clues to correct diagnosis.
Dahlbom K; Lindberg C; Oldfors A
Neuromuscul Disord; 2002 Nov; 12(9):853-7. PubMed ID: 12398837
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2, Bcl-x, and Bax expression by immunohistochemistry in inclusion body myositis: a study of 27 cases.
Prayson RA; Yu AC
Arch Pathol Lab Med; 2001 Oct; 125(10):1326-30. PubMed ID: 11570908
[TBL] [Abstract][Full Text] [Related]
3. Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis.
van der Meulen MF; Hoogendijk JE; Moons KG; Veldman H; Badrising UA; Wokke JH
Neuromuscul Disord; 2001 Jul; 11(5):447-51. PubMed ID: 11404115
[TBL] [Abstract][Full Text] [Related]
4. Absence of characteristic features in two patients with inclusion body myositis.
van der Meulen MF; Hoogendijk JE; Jansen GH; Veldman H; Wokke JH
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):396-8. PubMed ID: 9527159
[TBL] [Abstract][Full Text] [Related]
5. Congenital myopathy with abundant ring fibres, rimmed vacuoles and inclusion body myositis-type inclusions.
Fidziańska A; Kamińska A
Neuropediatrics; 2003 Feb; 34(1):40-4. PubMed ID: 12690567
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of manganese superoxide dismutase is associated with that of nitrotyrosine in myopathies with rimmed vacuoles.
Tsuruta Y; Furuta A; Taniguchi N; Yamada T; Kira J; Iwaki T
Acta Neuropathol; 2002 Jan; 103(1):59-65. PubMed ID: 11837748
[TBL] [Abstract][Full Text] [Related]
7. Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled.
van de Vlekkert J; Hoogendijk JE; de Visser M
Neuromuscul Disord; 2015 Jun; 25(6):451-6. PubMed ID: 25817837
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis.
Prayson RA; Cohen ML
Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of vacuolar muscle biopsies: use of p62, LC3 and LAMP2 immunohistochemistry.
Vittonatto E; Boschi S; CHIADò-Piat L; Ponzalino V; Bortolani S; Brusa C; Rainero I; Ricci F; Vercelli L; Mongini T
Acta Myol; 2017 Dec; 36(4):191-198. PubMed ID: 29770361
[TBL] [Abstract][Full Text] [Related]
10. [Inclusion body myositis: clinical and myopathological features].
Xie H; Wang L; Shen D
Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):610-2. PubMed ID: 10436972
[TBL] [Abstract][Full Text] [Related]
11. Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis.
Semino-Mora C; Dalakas MC
Hum Pathol; 1998 Oct; 29(10):1128-33. PubMed ID: 9781653
[TBL] [Abstract][Full Text] [Related]
12. Association between muscle strength, histopathology, and magnetic resonance imaging in sporadic inclusion body myositis.
Dahlbom K; Geijer M; Oldfors A; Lindberg C
Acta Neurol Scand; 2019 Feb; 139(2):177-182. PubMed ID: 30347435
[TBL] [Abstract][Full Text] [Related]
13. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
14. Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibres.
Arnardottir S; Borg K; Ansved T
J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):917-20. PubMed ID: 15146016
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.
Figarella-Branger D; Pellissier JF; Bianco N; Devictor B; Toga M
Acta Neuropathol; 1990; 79(5):528-36. PubMed ID: 2158202
[TBL] [Abstract][Full Text] [Related]
16. [Significance of rimmed vacuoles in neuromuscular disorders--a comparative immunohistochemical study of inclusion body myositis and distal myopathy with rimmed vacuole formation].
Murakami N; Takemitsu M; Kurashige T; Nonaka I
Rinsho Shinkeigaku; 1994 Aug; 34(8):782-7. PubMed ID: 7994984
[TBL] [Abstract][Full Text] [Related]
17. [Inclusion body myositis associated with sacroidosis: a report of 3 cases].
Bouillot S; Coquet M; Ferrer X; Lagueny A; Leroy JP; Vital C
Ann Pathol; 2001 Aug; 21(4):334-6. PubMed ID: 11685131
[TBL] [Abstract][Full Text] [Related]
18. Myopathy in a rhesus monkey with biopsy findings similar to human sporadic inclusion body myositis.
Skuk D; Goulet M; Paradis M; Tremblay JP
Neuromuscul Disord; 2013 Feb; 23(2):155-9. PubMed ID: 23200905
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.
Brady S; Squier W; Hilton-Jones D
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1240-6. PubMed ID: 23864699
[TBL] [Abstract][Full Text] [Related]
20. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
